Cargando…
Multi-Target Protective Effects of Gintonin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Mediated Model of Parkinson’s Disease via Lysophosphatidic Acid Receptors
Gintonin is a ginseng-derived lysophosphatidic acid receptor (LPAR) ligand. Although previous in vitro and in vivo studies demonstrated the therapeutic role of gintonin against Alzheimer’s disease, the neuroprotective effects of gintonin in Parkinson’s disease (PD) are still unknown. We investigated...
Autores principales: | Choi, Jong Hee, Jang, Minhee, Oh, Seikwan, Nah, Seung-Yeol, Cho, Ik-Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974039/ https://www.ncbi.nlm.nih.gov/pubmed/29875659 http://dx.doi.org/10.3389/fphar.2018.00515 |
Ejemplares similares
-
Effects of Gintonin-enriched fraction on the gene expression of six lysophosphatidic receptor subtypes
por: Lee, Rami, et al.
Publicado: (2021) -
Ginseng pharmacology: a new paradigm based on gintonin-lysophosphatidic acid receptor interactions
por: Choi, Sun-Hye, et al.
Publicado: (2015) -
e-Cadherin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson Disease
por: Cataldi, Samuela, et al.
Publicado: (2016) -
Sphingosine-1-Phosphate Receptors Modulators Decrease Signs of Neuroinflammation and Prevent Parkinson’s Disease Symptoms in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model
por: Pépin, Élise, et al.
Publicado: (2020) -
Neuroprotective and Neurorescue Mode of Action of Bacopa monnieri (L.) Wettst in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson’s Disease: An In Silico and In Vivo Study
por: Singh, Babita, et al.
Publicado: (2021)